Old Web
English
Sign In
Acemap
>
Paper
>
BIOMARKER‐DRIVEN TREATMENT STRATEGY IN HIGH RISK DIFFUSE LARGE B‐CELL LYMPHOMA: RESULTS OF A NORDIC PHASE 2 STUDY
BIOMARKER‐DRIVEN TREATMENT STRATEGY IN HIGH RISK DIFFUSE LARGE B‐CELL LYMPHOMA: RESULTS OF A NORDIC PHASE 2 STUDY
2021
Sirpa Leppä
Judit Jørgensen
M‐L Karjalainen‐Lindsberg
Klaus Beiske
Peter Nørgaard
K Drott
Annika Pasanen
Kristiina Karihtala
S. Mannisto
B Wold
Marianne Brodtkorb
Unn‐M Fagerli
Thomas Stauffer Larsen
Lars Munksgaard
Øystein Fluge
Sirkku Jyrkkiö
P. Brown
Harald Holte
Keywords:
Biomarker (medicine)
Diffuse large B-cell lymphoma
treatment strategy
Phases of clinical research
Cancer research
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]